KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Equity Income (2016 - 2025)

Precigen (PGEN) has disclosed Equity Income for 11 consecutive years, with -$111.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Income changed N/A to -$111.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$139.5 million, a N/A change, with the full-year FY2022 number at $862000.0, up 28833.33% from a year prior.
  • Equity Income was -$111.5 million for Q3 2025 at Precigen, down from $4.5 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $4.5 million in Q2 2025 to a low of -$111.5 million in Q3 2025.
  • A 3-year average of -$19.8 million and a median of -$1000.0 in 2022 define the central range for Equity Income.
  • Peak YoY movement for Equity Income: skyrocketed 99.23% in 2021, then skyrocketed 66.67% in 2022.
  • Precigen's Equity Income stood at -$3000.0 in 2021, then soared by 133.33% to $1000.0 in 2022, then crashed by 11150300.0% to -$111.5 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Equity Income are -$111.5 million (Q3 2025), $4.5 million (Q2 2025), and -$32.5 million (Q1 2025).